The 4th Annual Gene Therapy for Ophthalmic Disorders Summit is the industry-leading, industry-focused forum for learning how to validate novel administration routes to the eye, extrapolate effectively from preclinical models to inform safety and efficacy and define relevant endpoints for clinical trials.

Across 3 days of in-depth case studies, new data, and focused group discussions, hear from and engage with the likes of Janssen, Adverum Biotechnologies, Spark Therapeutics, SparingVision, AbbVie, and the RD Fund. As well as leveraging insights from these talks and panels: participate in breakout discussions, utilize Q&A time built into talks, and meet and learn from ophthalmic gene therapy leaders during our 5+ hours of dedicated networking time.

This Summit Will Bring Together Leading Voices on:

- Defining Relevant and Meaningful Endpoints
Investigate the latest trends in endpoint development and regulation, understand their applicability in animal model studies to clinical trials, and discuss the need for validated novel endpoints, with key insights from Adverum Biotechnologies and SparingVision.

- Levelling up the Translatability of Preclinical Models
Address the best practices in animal model selection and development, optimize the clinical relevancy of animal model studies, and leverage the latest retinal organoid developments, with expert sessions hosted by Atsena Therapeutics and MeiraGTx.

- Exploring Different Delivery Methods to the Front and Back of the Eye
Take a deep dive into the suprachoroidal route, overcome the AAV cargo capacity challenge with novel administration methods, and hear the latest updated on robotics-assisted subretinal delivery, with exciting discussions from Clearside Biomedical and Splice Bio.

- Understanding the Immune and Inflammatory Responses to Ocular Gene Therapies
How can improved promoters and enhancers deliver genes effectively without triggering the immune response? Which preclinical models are best suited to test the various variables associated with GTAU? What are the latest trends in immunosuppressant regimens being used in the field? Let AGTC and Kriya Therapeutics answer these questions, and many more.

- Leveraging Insights from Ophthalmology-Focused Venture Capital
Discover the current investment landscape for gene therapy in the ophthalmology field, and understand what venture capital investors are looking for when it comes to developing preclinical, clinical, and manufacturing packages in the most fruitful, cost-effective manner, with key insights from the RD Fund and Syncona.
Read on ophthalmology.com

Join us for our 4th Annual Connected Health Virtual Summit as we dive into the latest ways to advance connected care efforts, such as leveraging wearables, addressing SDOH and patient engagement methods. Our curated experts will also discuss enhancing processes to facilitate connection, including using audio-only, asynchronous telehealth to boost healthcare access, and integrating care technology to expand behavioral health services.

Read on xtelligentvirtualsummits.brighttalk.com

The first commercial TIL therapy is brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, along with the 5th TIL Therapies Summit which returns as the only forum to address bottlenecks in end-to-end TIL development from discovery now through to commercialization.

Unite with TIL experts across industry and academia as pioneers from Iovance Biotherapeutics, Turnstone Biologics, Achilles Therapeutics and Lyell Immunopharma share clinical updates, next-gen engineering, and novel innovations to reduce cost and turnaround time to turbocharge preclinical and clinical development of safe, scalable and effective TIL therapies.

With 23+ TIL expert speakers, 75% of which new, 8 new companies and a brand-new Manufacturing and Characterization Bootcamp, you won't want to miss this unrivalled opportunity to connect and collaborate with this niche community to secure clinical validation, turbocharge modified therapies and accelerate the next wave of TIL therapies into the clinic and beyond.

Read on go.evvnt.com

The chemical and pharma industries are fast moving and ever changing and the efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently and sustainably. OPR&D focusses on all these essential aspects of the chemical industry and has a reputation for quality and excellence.

Read on scientificupdate.com

We are so delighted to bring our 50th OPRD Conference to Barcelona

Join us in this fantastic location and you will enjoy hearing cutting edge Scientific Content alongside our renowned Networking Receptions. You will have the chance to connect with other like-minded chemists and benefit from Questions & Answer sessions and scientific discussion after each presentation.

Whether you are looking to learn about the latest scientific updates from industry or to meet and network with other chemists – our OPR&D Conference is the place to be.

We invite key industrial experts from around the globe to share their discoveries with you. Each speaker is hand-picked and we work hard to ensure that a wide variety of topics are covered to ensure our programme is comprehensive and relevant. You will be re-invigorated and boosted once back in the lab.

Come and improve your efficiency and learn how to be more innovative in your synthetic route design, development and optimisation.

The chemical and pharma industries are fast moving and ever changing and the efficient conversion of a chemical process into a process for manufacture on tonnage scale has always been of importance. However, in the current economic and regulatory climate, it has become increasingly vital and challenging to do so efficiently and sustainably. OPR&D focusses on all these essential aspects of the chemical industry and has a reputation for quality and excellence.

Read on go.evvnt.com

International Conference on Recent Advances in Medical, Medicine and Health Science will be held on 01st Oct-02nd Oct 2023 at  Singapore. ICRAMMHS aims to foster collaboration among innovative academics and industry experts in the field of Business Management and Social Innovation. Registered papers will be published by the World Research Library and considered for indexing by Google Scholar. With sponsorship from various international institutes, the conference features renowned speakers, Best Paper Awards, and rigorous peer review. Accepted papers will be published in conference proceedings with an ISBN number, and extended versions will be published in reputable Scopus/SCI/WoS/UGC Care Listed international journals.

Read on wrfer.org

The International Conference on Medical, Pharmaceutical, and Health Sciences (ICMPH) is scheduled for October 2-3, 2023, in Malé, Maldives, organized by the Global Society for Research and Development (GSRD). It aims to facilitate knowledge exchange among students, engineers, researchers, and scientists in the realms of Science, Engineering & Technology. ICMPH provides a global forum for advancements in Medical, Pharmaceutical, and Health Sciences, uniting academia and industry professionals to showcase cutting-edge developments.

Read on gsrd.co

The International Conference on Bioinformatics, Biomedicine, Biotechnology, and Computational Biology (EUIC3BCB) is scheduled to be held in Benin City, Nigeria on 1st October 2023. This conference series offers a platform for interactive presentations and discussions on various topics within the fields of Bioinformatics, Biomedicine, Biotechnology, and Computational Biology. Professionals worldwide interested in establishing professional connections or exploring career opportunities in the region are welcome to participate. The conference facilitates the exchange of knowledge and insights into the latest technology, techniques, and solutions in Biotechnology as applied in different countries. Participants range from research and academia to industry and government sectors.

Read on eurasiaweb.com

Join RIT and the New York State HIMSS Chapter on October 2, 2023, to tackle healthcare cybercrime. Discover strategies to prevent and respond to threats, hear real case studies, and learn from security experts. This event aims to unite Upstate NY stakeholders for stronger healthcare security and offers vendors a chance to connect with regional partners.

Read on himss.org

There’s more data than ever before, but our commercial and marketing strategies aren’t capitalizing on it. Why? We still haven’t worked out how to turn mass data into personalized insights and next best action generation. Now you have the technology to transform your data into new and exciting commercial opportunities, by curating customized messaging that will finally allow you to surpass your competitors. That’s why 300+ Marketing, Digital, Analytics, Data, Commercial, IT and Brand leaders came together at Reuters Events: Customer Engagement USA 2023 to put this into practice. Backed by a brand you can trust, Customer Engagement USA 2023 will open your eyes to the new world of data-driven, digital engagement that awaits you.

Read on events.reutersevents.com